| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 53.3% | 8/15 |
| Female | 46.7% | 7/15 |
| Indifferent | 0% | 0/15 |
| Unknown | 0% | 0/15 |
| General | ||
| 13.3% | 2/15 | |
| 46.7% | 7/15 | |
| Birth Head circumference | 0% | 0/15 |
| 26.7% | 4/15 | |
| 13.3% | 2/15 | |
| 26.7% | 4/15 | |
| 100% | 15/15 | |
| 100% | 15/15 | |
| 46.7% | 7/15 | |
| 85.7% | 6/7 | |
| Neurology | ||
| 93.3% | 14/15 | |
| 66.7% | 10/15 | |
| 80% | 12/15 | |
| Facial abnormalities | ||
| 100% | 15/15 | |
| 93.3% | 14/15 | |
| 80% | 12/15 | |
| 86.7% | 13/15 | |
| Visual and hearing impairments | ||
| 53.3% | 8/15 | |
| 33.3% | 5/15 | |
| Heart | ||
| 80% | 12/15 | |
| Pulmonary | ||
| 14.3% | 2/14 | |
| Gastrointestinal | ||
| 80% | 12/15 | |
| Urogenital | ||
| 26.7% | 4/15 | |
| Skeleton | ||
| 93.3% | 14/15 | |
| Skin / Hair / Nails | ||
| 86.7% | 13/15 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/15 |
| 6.7% | 1/15 | |
| 33.3% | 5/15 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/15 |
| Inheritance | ||
| 100% | 14/14 | |
PCGF2